格特隐球菌交配型的多重PCR鉴定

【目的】建立一种基于格特隐球菌α交配型位点内SXI1α基因和a交配型位点内SXI2a基因的多重PCR分析,用于快速鉴定格特隐球菌的交配型。【方法】设计针对格特隐球菌α交配型位点内SXI1α基因部分片段和格特隐球菌a交配型位点内SXI2a基因部分片段的特异性引物,用于多重PCR鉴定格特隐球菌的交配型;并与交配试验以及已报道的扩增α交配型位点的引物MFα、STE12α,及扩增a交配型位点的引物STE20a、STE3a进行扩增效果的比较。【结果】基于SXI1α基因和SXI2a基因的多重PCR分析,准确鉴定所有受试格特隐球菌(包括VGI、VGII、VGIII和VGIV基因型)的交配型,引物STE12α、STE20a和STE3a在常规PCR鉴定中不能鉴定部分菌株的交配型;66.7%的受试菌株不能发生交配,交配试验无法鉴定其交配型。【结论】建立的多重PCR方法明显优于常规PCR或交配试验鉴定。     

格特隐球菌核基因、交配型位点和线粒体基因的多位点序列分型及重组分析

研究格特隐球菌VGI和VGII基因型菌株间线粒体基因重组与核基因、交配型位点重组间的关系。采用分子鉴定区分受试格特隐球菌的血清型、基因型和交配型;选取包含核基因和线粒体基因10个位点的多位点序列分型（ MLST）进行基因型和系统发育分析;采用同质性检验评价基因系谱间的一致性。多位点的序列和系统发育分析结合同质性检验表明,受试位点中,仅ATP6位点发现VGI和VGII菌株间基因的杂交和重组,该基因系谱与其余位点的基因系谱呈现不一致性。结果显示,受试的部分VGI菌株中的ATP6位点含有VGII菌株的基因序列,表明VGI和VGII菌株间线粒体基因的重组;没有发现核基因及交配型位点中两者间的重组,提示VGI和VGII菌株间线粒体基因的重组现象与交配行为无关。     

中国广西地区格特隐球菌菌种复合体的基因型分析

目的探讨中国广西地区格特隐球菌菌种复合体的基因型特点、种群结构特征和全球菌株的进化关系。方法收集2014—2018年间分离自临床确诊为隐球菌病患者的隐球菌临床株,利用CGB培养基初步筛选格特隐球菌菌种复合体。采用多位点序列分型方法(MLST)确定基因型。通过MEGA7软件构建系统发育树,利用R语言进行主成分分析。使用微量肉汤稀释法M27-A3方案行体外抗真菌药物敏感性检验。结果120株临床隐球菌中,分离出11株格特隐球菌菌种复合体,6株属于C.deuterogattii(AFLP6/VGII),5株属于C.gattii sensus stricto(AFLP4/VGI)。分离自广西的AFLP6/VGII呈遗传多样性,主要起源进化自南美巴西格特隐球菌菌种复合体。11株分离菌株均对常用抗真菌药物敏感。结论中国广西可能出现高致病性AFLP6/VGII,对格特隐球菌菌种复合体进行有效的全国性监测是必要的。     

格特隐球菌IGS5b基因亚型和a交配型菌株的鉴定

目的鉴定1株格特隐球菌VGⅢ基因型中的少见基因亚型IGS5b及a交配型菌株。方法采用PCR指纹法、基因内间隔区（IGS）和磷脂酶基因（PLB1）测序分析鉴定基因型。采用PCR特异扩增法和交配试验鉴定交配型。采用GEF1基因序列分析同步鉴定基因型和交配型。结果结合PCR指纹法和序列分析,鉴定受试株RV63979为VGⅢ基因型中的少见基因亚型。针对交配型位点内STE12和STE20基因的特异性引物均扩增阴性。交配试验证实为a交配型。GEF1位点测序准确鉴定其基因型和交配型。结论本文通过多种鉴定手段结合IGS序列分析,鉴定1株VGⅢ基因型中的少见基因亚型IGS5b,证实VGⅢ基因型中至少存在IGS5a和IGS5b2种基因亚型。交配型分析表明该菌为VGⅢ基因型中少见的a交配型。     

格特隐球菌HOG1基因的敲除及重建

目的 构建格特隐球菌HOG1基因缺陷株和HOG1基因重建株.方法 从格特隐球菌基因组扩增HOG1基因,通过部分基因缺失方法,获得缺陷基因dHOG1.将获得的HOG1基因及其缺陷基因dHOG1分别亚克隆到真核表达载体pGAPzα-A,构建pGAPzα-HOG1及pGAPzcα-dHOG1质粒.将pGAPzα-dHOG1质粒转染隐球菌原始株,通过筛选获得HOG1基因缺陷菌株;同样方法将pGAPzα-HOG1质粒转染格特隐球菌HOGI基因敲除菌株,获得HOGI基因重建株.结果 RTPCR结果示:格特隐球菌HOG1基因缺陷株不转录表达完整的HOG1基因,而HOG1基因重建株可以转录表达完整的HOG1基因片段.结论 成功获得格特隐球菌HOG1缺陷株和HOG1基因重建株,为后续格特隐球菌毒力和致病机制的研究奠定了基础.     

新型隐球菌临床菌株中CNAG_01032基因的鉴定和功能研究

新型隐球菌是一种具有荚膜的重要临床致病真菌。本课题组在前期工作中发现CNAG_01032基因可能引起不同来源菌株的表型差异,本研究在此基础上以新型隐球菌临床来源菌株IFM56800（C1）、IFM56769（C2）为背景构建CNAG_01032基因敲除突变体,并检测突变株和野生型菌株经典毒力因子变化情况;使用API 20C AUX测试系统测试突变株和野生型菌株对19种糖的利用情况;使用尾静脉注射法感染BALB/c雌性小鼠进行致病性检测。结果显示：成功构建以临床株C1、C2为背景的CNAG-01032基因敲除突变株;突变株在37℃生长、黑色素产生与野生型菌株无显著差异,但荚膜厚度分别比C1、C2减少16.4%、18.2%;两基因敲除菌株均不能分解利用纤维二糖;致病性与野生型菌株无显著差异。新型隐球菌CNAG_01032基因可能参与临床来源菌株IFM56800、IFM56769的荚膜合成和纤维二糖的代谢。     

新生隐球菌一个新的产孢相关蛋白Srp1的鉴定与功能分析

【目的】研究产孢相关蛋白Srp1在新生隐球菌有性产孢和致病性中的作用及机理。【方法】采用基因枪转化技术构建新生隐球菌SRP1基因缺失突变体及其互补菌株,并通过小鼠致病性实验和菌株交配实验检测Srp1在新生隐球菌有性产孢和致病性中的作用。【结果】与野生型菌株相比,srp1Δ突变体小鼠致病性无差异;srp1Δ突变体能够交配并形成双核菌丝,但丧失产生担孢子的能力;初步机理分析表明srp1Δ突变体交配后其减数分裂过程被阻断,从而导致srp1Δ突变体不能产生担孢子。【结论】产孢相关蛋白Srp1不影响新生隐球菌的致病性,但可通过调控减数分裂过程影响新生隐球菌的有性生殖。     

基于全基因组关联分析研究粪肠球菌发酵食品分离株的耐药性

【目的】研究15株分离自自然发酵食品的粪肠球菌(Enterococcus faecalis)和1株粪肠球菌模式株对15种(1种β-内酰胺类和14种非β-内酰胺类)抗生素的耐药性,并通过菌株耐药表型与基因型的关联分析找到粪肠球菌潜在的耐药基因。【方法】利用微量肉汤稀释法检测试验菌株对15种抗生素的耐药性,运用Scoary软件进行表型与基因型的关联分析。【结果】16株粪肠球菌对卡那霉素、万古霉素、利奈唑胺和红霉素100%敏感;对其余11种抗生素均表现出不同程度的耐药,其中对克林霉素为100%耐药。基因组关联分析发现了9个功能基因与5种抗生素(氯霉素、环丙沙星、甲氧苄啶、新霉素和四环素)存在显著相关关系,其中基因FAM000296和FAM005768与氯霉素、甲氧苄啶和环丙沙星的耐药性有关。进一步分析发现基因FAM000296和FAM005768同被注释为Sec G,但基因FAM005768与基因FAM000296相比在3′端丢失了21个碱基。【结论】分离自自然发酵食品的粪肠球菌对多种抗生素具有耐药性,其基因组中携带有潜在的耐药基因。因此,对分离自自然发酵食品的粪肠球菌需要进行全面的安全性评估后方可考虑应用。     

苏云金芽胞杆菌LM1212菌株和突变株的全基因组序列比较分析

【背景】LM1212菌株是昆虫病原菌苏云金芽胞杆菌(Bacillus thuringiensis,Bt)中的一员,其芽胞和晶体分别产生于芽胞形成细胞和晶体产生细胞中,具有独特的细胞分化表型。与野生株LM1212相比,突变株LM1212-DB芽胞细胞比例明显降低并产生更高比例的晶体产生细胞,这使得LM1212-DB菌株成为研究晶体产生细胞形成机制和提高菌株杀虫活性的绝佳实验材料。【目的】比较LM1212菌株和LM1212-DB菌株的基因组差异,以便于揭示导致这两个菌株表型差异的原因。【方法】利用单分子测序技术(single molecular real-time,SMRT)和Pacbio RS II测序平台对两个菌株进行全基因组测序,对染色体和质粒、双组分信号系统和插入序列等进行差异分析,并构建表型特性相关基因的系统发育树。【结果】基因组分析发现,LM1212和LM1212-DB菌株均含有丰富的插入序列和双组分信号系统,暗示两个菌株极易发生基因重排且具有较强的环境适应性。与LM1212菌株相比,突变株LM1212-DB中发生了染色体和质粒片段缺失、质粒重排、质粒拷贝数变异。进一步分析缺失基因的功能发现,一些环境胁迫响应基因(如sigB)和芽胞形成相关基因(如abrB)等缺失;通过分析质粒拷贝数变异发现,具有增加晶体细胞比例功能的转录因子CpcR所在质粒的拷贝数增加1个,同时对CpcR的进化分析发现,与其亲缘关系最近的基因的从属菌株也产生与LM1212菌株相似的细胞分化表型。这些重要功能基因的缺失和拷贝数变异可能是导致两个菌株表型差异的原因。此外,突变株LM1212-DB缺失I型限制-修饰系统,这使得突变株LM1212-DB与野生菌株LM1212相比具有更好的外源DNA兼容性。【结论】突变株LM1212-DB染色体和质粒的结构变异可能是导致与野生株LM1212表型差异的潜在原因,这将为研究LM1212菌株的晶体细胞分化机制提供指导方向。     

新疆首次临床分离新生隐球菌菌株分子鉴定、基因分型及体外药物敏感性研究

目的对新疆首次临床分离的5株新生隐球菌进行分子鉴定、RAPD-PCR基因分型及体外药物敏感性研究。方法5株新生隐球菌分子鉴定采用核糖体DNA大亚基(LSU rDNA)D1/D2基因区域分子鉴定。分子分型采用引物SEQ-6结合RAPD-PCR法扩增5株新疆临床分离新生隐球菌菌株及5株由上海长征医院提供分离自上海新生隐球菌菌株,根据扩增产物带型进行基因型判定。采用临床实验室标准化协会(CLSI)的酵母微量液基稀释法(M27-A3)测定5株新疆临床分离新生隐球菌菌株对6种抗真菌药(伏立康唑、伊曲康唑、两性霉素B、特比萘芬、氟康唑、5-氟胞嘧啶)的体外敏感性。结果 5株新疆临床分离隐球菌菌株经过D1/D2区域序列分析在基因Bank中比对后鉴定为新生隐球菌。5株新疆临床分离新生隐球菌和5株上海新生隐球菌菌株经RAPD-PCR法扩增,带型显示分为A、B、C、D 4个基因型,其中新疆5株菌株A型1株、其余4株均为B型,上海菌株B型为1株,C型3株、D型1株,5株新疆临床分离新生隐球菌株对伏立康唑、伊曲康唑、两性霉素B、特比萘芬的MIC值(μg/mL)范围依次为:0.062 5~0.25、0.25~1、0.125~0.5、1~2,对氟康唑、5-氟胞嘧啶MIC值较高,MIC值范围依次为:4~16、8~32。结论新疆临床分离5株隐球菌株采用D1/D2基因序列鉴定为新生隐球菌。RAPD-PCR分型显示新疆临床分离5株新生隐球菌株以B型基因型为主。A型和B型对伏立康唑、两性霉素B敏感,对伊曲康唑、特比萘芬剂量依赖型敏感,对氟康唑、5-氟胞嘧啶耐药。     

A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility

正Dear Editor,In December 2019, a novel human coronavirus caused an epidemic of severe pneumonia(Coronavirus Disease 2019,COVID-19) in Wuhan, Hubei, China(Wu et al. 2020; Zhu et al. 2020). So far, this virus has spread to all areas of China and even to other countries. The epidemic has caused 67,102 confirmed infections with 1526 fatal cases     

Curcuminoids as inhibitors of thioredoxin reductase: A receptor based pharmacophore study with distance mapping of the active site

Curcumin is the yellow pigment of turmeric that interacts irreversibly forming an adduct with thioredoxin reductase (TrxR), an enzyme responsible for redox control of cell and defence against oxidative stress. Docking at both the active sites of TrxR was performed to compare the potency of three naturally occurring curcuminoids, namely curcumin, demethoxy curcumin and bis-demethoxy curcumin. Results show that active sites of TrxR occur at the junction of E and F chains. Volume and area of both cavities is predicted. It has been concluded by distance mapping of the most active conformations that Se atom of catalytic residue SeCYS498, is at a distance of 3.56 from C13 of demethoxy curcumin at the E chain active site, whereas C13 carbon atom forms adduct with Se atom of SeCys 498. We report that at least one methoxy group in curcuminoids is necessary for interation with catalytic residues of thioredoxin. Pharmacophore of both active sites of the TrxR receptor for curcumin and demethoxy curcumin molecules has been drawn and proposed for design and synthesis of most probable potent antiproliferative synthetic drugs.     

The structure, reproduction and taxonomy of Vidalia and Osmundaria (Rhodophyta, Rhodomelaceae)

Comprises species occurring mostly in subtidal habitats in tropical, subtropical and warm-temperate areas of the world. An analysis of the type species, V. spiralis (Sonder) Lamouroux ex J. Agardh, a species from Australia, establishes basic characters for distinguishing species in the genus. These characters are (1) branching patterns of thalli, (2) flat blades that may be spiralled on their axis, (3) width of the blade, (4) primary or secondary derivation of sterile and fertile branchlets and (5) position of sterile and fertile branchlets on the thalli. Application of the latter two characters provides an important basic method for separation of species into three major groups. Osmundaria , a genus known only in southern Australia, was studied in relation to Vidalia , and its separation from the Vidalia assemblage is not accepted. Species of Vidalia therefore are transferred to the older genus name, Osmundaria. Two new species, Osmundaria papenfussii and Osmundaria oliveae are described from Natal. Confusion in the usage of the epithet, Vidalia fimbriala Brown ex Turner has been clarified, and Vidalia gregaria Falkenberg, described as an epiphyte on Osmundaria pro/ifera Lamouroux, is revealed to be young branches of the host, Osmundaria prolifera.     

New or rare chromosome counts in Artemisia L. (Asteraceae, Anthemideae) and related genera from Kazakhstan

Fifteen chromosome counts of six Artemisia taxa and one species of each of the genera Brachanthemum, Hippolytia, Kaschgaria, Lepidolopsis and Turaniphytum are reported from Kazakhstan. Three of them are new reports, two are not consistent with previous counts and the remainder are confirmations of very scarce (one to four) earlier records. All the populations studied have the same basic chromosome number, x = 9, with ploidy levels ranging from 2x to 6x. Some correlations between ploidy level, morphological characters and distribution are noted.     

Comparative morphology of the carpel in the Liliaceae: Hewardieae, Petrosavieae, and Tricyrteae

The young pistils in the melanthioid tribes, Hewardieae, Petrosavieae and Tricyrteae, are uniformly tricarpellate and syncarpous. They lack raphide idioblasts. All are multiovulate, with bitegmic ovules. The Petrosavieae are marked by the presence of septal glands and incomplete syncarpy. Tepals and stamens adhere to the ovary in the Hewardieae and the Petrosavieae but not in the Tricyrteae. Two vascular bundles occur in the stamens of the Hewartlieae and Tricyrtis latifolia. Ventral bundles in the upper part of the ovary of the Hewardieae are continuous with compound septal bundles and placental bundles in the lower part. Putative ventral bundles occur in the alternate position in the Tricyrteae and putative placental bundles in the opposite. position in the Petrosavieae. The dichtomously branched stigma in each carpel of the Tricyrteae is supplied by a bifurcated dorsal bundle.     

肝癌中HBV和HCV基因和抗原的分布及意义

采用原位分子杂交方法检测HCV RNA及HBV X基因;采用免疫组织化学方法研究HCV核心抗原,非结构区C33c抗原及HBxAg在肝细胞肝癌中的定位及分布.结果表明(1)HCV RNA、HBV X基因在肝细胞肝癌组织检出率分别为40%(55/136)和82%(112/136).HCV RNA定位于癌细胞的胞浆内,阳性细胞呈散在、灶状及弥漫分布三种形式;HBV X基因在肝癌细胞中的分布呈胞浆型、核型及核浆型,阳性细胞也呈上述三种分布形式;(2)HCV C33c抗原、核心抗原在肝细胞肝癌中的阳性率为81%(133/164)及86%(141/164).C33c抗原定位于癌细胞及肝细胞的胞浆内;核心抗原既定位于癌细胞核中,又可定位于胞浆中.C33c抗原阳性细胞以灶状分布为主;而核心抗原阳性细